Scholarlink

Introduction and Hypothesis <p>To evaluate the clinical efficacy and safety of combined sacral magnetic stimulation (SMS) and bladder electrical stimulation (ES) in treating post-stroke urgency urinary incontinence (UUI).</p> Methods <p>We retrospectively enrolled 90 patients with post-stroke UUI, divided into ES, SMS, and SMS + ES groups (<i>n</i> = 30 each). Urodynamic parameters, voiding diaries, quality of life scales (ICIQ-SF, ICIQ-QoL, SAS), Patient Global Impression of Improvement (PGI-I), urinary tract infection (UTI) incidence, and overall response rates were compared before and 1 month after treatment.</p> Results <p>The SMS + ES group demonstrated comprehensive therapeutic advantages. Urodynamically, this group showed significantly greater maximum bladder capacity (408.5 ± 70.1&#xa0;mL), lower postvoid residual urine volume (75.2 ± 53.4&#xa0;mL), and lower detrusor pressure at maximum flow (28.4 ± 6.5 cmH<sub>2</sub>O) compared to single-therapy groups (all <i>P</i> &lt; 0.01). Clinically, the combined group showed the most significant improvements in 24-h incontinence episodes, ICIQ-SF, ICIQ-QoL, and SAS scores (all <i>P</i> &lt; 0.01), along with the best PGI-I scores. The UTI incidence was 3.3% in the SMS + ES group, significantly lower than the 13.3% in the ES group (<i>P</i> &lt; 0.05). The overall response rate was 93.3% in the SMS + ES group, significantly higher than in the ES (66.7%) and SMS (73.3%) groups (<i>P</i> &lt; 0.05).</p> Conclusion <p>Combined SMS and ES therapy synergistically improves storage and voiding function, alleviates anxiety, reduces UTI risk, and significantly enhances quality of life in post-stroke UUI patients, demonstrating superior efficacy over either therapy alone.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sacral and Bladder Stimulation Synergistically Treat Post-Stroke Urgency Incontinence

  • 期刊论文

  • 发表日期：

    2026年1月24日

查看全文
  • Jingjing Shi,
  • Chen Song,
  • Yanbin Wang,
  • Junhua Li,
  • Huixian Pan

摘要

Introduction and Hypothesis

To evaluate the clinical efficacy and safety of combined sacral magnetic stimulation (SMS) and bladder electrical stimulation (ES) in treating post-stroke urgency urinary incontinence (UUI).

Methods

We retrospectively enrolled 90 patients with post-stroke UUI, divided into ES, SMS, and SMS + ES groups (n = 30 each). Urodynamic parameters, voiding diaries, quality of life scales (ICIQ-SF, ICIQ-QoL, SAS), Patient Global Impression of Improvement (PGI-I), urinary tract infection (UTI) incidence, and overall response rates were compared before and 1 month after treatment.

Results

The SMS + ES group demonstrated comprehensive therapeutic advantages. Urodynamically, this group showed significantly greater maximum bladder capacity (408.5 ± 70.1 mL), lower postvoid residual urine volume (75.2 ± 53.4 mL), and lower detrusor pressure at maximum flow (28.4 ± 6.5 cmH2O) compared to single-therapy groups (all P < 0.01). Clinically, the combined group showed the most significant improvements in 24-h incontinence episodes, ICIQ-SF, ICIQ-QoL, and SAS scores (all P < 0.01), along with the best PGI-I scores. The UTI incidence was 3.3% in the SMS + ES group, significantly lower than the 13.3% in the ES group (P < 0.05). The overall response rate was 93.3% in the SMS + ES group, significantly higher than in the ES (66.7%) and SMS (73.3%) groups (P < 0.05).

Conclusion

Combined SMS and ES therapy synergistically improves storage and voiding function, alleviates anxiety, reduces UTI risk, and significantly enhances quality of life in post-stroke UUI patients, demonstrating superior efficacy over either therapy alone.